Curaleaf (OTCMKTS:CURLF) Trading Up 12.2% – Here’s What Happened

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) shares traded up 12.2% on Tuesday . The stock traded as high as $2.12 and last traded at $2.12. 373,478 shares traded hands during trading, a decline of 58% from the average session volume of 896,871 shares. The stock had previously closed at $1.89.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the company. Alliance Global Partners restated a “buy” rating on shares of Curaleaf in a report on Monday, December 22nd. Zacks Research raised Curaleaf from a “strong sell” rating to a “hold” rating in a report on Thursday, January 1st. Two analysts have rated the stock with a Strong Buy rating, one has given a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Buy”.

Curaleaf Price Performance

The stock has a fifty day moving average price of $2.32 and a 200-day moving average price of $2.59. The company has a market cap of $1.52 billion, a PE ratio of -7.43 and a beta of 0.71. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.52 and a quick ratio of 0.76.

Curaleaf (OTCMKTS:CURLF) last issued its quarterly earnings results on Thursday, February 26th. The company reported ($0.05) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.03. The business had revenue of $333.07 million for the quarter, compared to the consensus estimate of $328.70 million. Curaleaf had a negative return on equity of 23.17% and a negative net margin of 18.08%. On average, equities analysts expect that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current year.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.